Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
Treatment with Viread and Baraclude led to a decline in liver cancer in Europe but not in South Korea.
An analysis of two Gilead-sponsored studies suggests that black HIV-positive patients have a better chances of an undetectable viral load afte...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.